Q4 & FY22 Highlights slide image

Q4 & FY22 Highlights

Genevolve: The Genomics initiative • GENEVOLVE- Genetic Testing Your Smart Choice We are celebrating our 2 nd Anniversary- MIX GENEVOLVE Dr Lal PathLabs genetic TESTING YOUR SMART CHOICE Genevolve: Genomics division focuses on Genetic testing Offers wide range of key tests related to Oncogenomics, Neurogenomics, Rare disease & Pre- natal/Post-natal Tests are carried out using cutting edge technologies such as Next Generation Sequencing (NGS), MLPA, ddPCR, FISH & Sanger Sequencing among others New Tests 63 New Test Launched- Oncogenomics & Neurogenomics New Tie-ups I . Caris Inc. (USA) • Foundation Medicine • Novartis • • ONCOPATH Leaders in Oncopath In-House Testing Capabilities PAN India network of clinical laboratories, collection centers and pick-up points makes Dr. Lal PathLabs the most reliable genetic testing service provider in India Widest test range solutions for Cancer- Hematological Malignancies, Solid Tumor including multigene panels, Molecular Profiles & Panels in combinations with IHC 39 Dr Lal PathLabs
View entire presentation